Cargando…
Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review
Approximately 50–60% of all patients with amyotrophic lateral sclerosis (ALS) will develop a deficit of frontotemporal function, ranging from frontotemporal dementia (FTD) to one or more deficits of neuropsychological, speech or language function which are collectively known as the frontotemporal sp...
Autores principales: | Moszczynski, Alexander J., Hintermayer, Matthew A., Strong, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919950/ https://www.ncbi.nlm.nih.gov/pubmed/29731706 http://dx.doi.org/10.3389/fnins.2018.00259 |
Ejemplares similares
-
Threonine(175), a novel pathological phosphorylation site on tau protein linked to multiple tauopathies
por: Moszczynski, Alexander J., et al.
Publicado: (2017) -
(18)
F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis– Frontotemporal Spectrum Disorder (ALS-FTSD)
por: Mashriqi, Faizullah, et al.
Publicado: (2023) -
Alterations in Tau Metabolism in ALS and ALS-FTSD
por: Strong, Michael J., et al.
Publicado: (2020) -
Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS
por: Moszczynski, Alexander J., et al.
Publicado: (2018) -
Upregulation of LRRK2 following traumatic brain injury does not directly phosphorylate Thr(175) tau
por: Donison, Neil, et al.
Publicado: (2023)